+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Omega 3 Prescription Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • PDF Icon

    Report

  • 84 Pages
  • May 2025
  • Region: Global
  • Prof Research
  • ID: 6090502
Description Jump to:
Omega 3 prescription drugs, such as Vascepa and Lovaza, target cardiovascular diseases (CVD), responsible for 17.9 million deaths annually, and high triglyceride levels affecting 25% of U.S. adults. The market is driven by an aging population (1 billion over 60 in 2020, projected to reach 2.1 billion by 2050), rising consumer awareness of omega-3 benefits, and novel formulations like high-purity EPA, improving bioavailability by 10%. Regulatory approvals, such as Vascepa for CVD risk reduction in 2020, and supportive guidelines from AHA and WHO further boost demand. The global omega 3 prescription drugs market is estimated at USD 700-1,400 million in 2025, with a CAGR of 3%-7% through 2030.

Regional Market Trends

  • North America: The U.S. dominates with high CVD prevalence and Vascepa adoption, while Canada focuses on preventive care.
  • Europe: Germany, France, and the UK drive growth with robust CVD management programs.
  • Asia Pacific: Japan and China see rising demand due to aging populations, with India emphasizing affordable generics.
  • Rest of the World: Brazil expands CVD treatment access, while the Middle East addresses metabolic disorders.

Distribution Channel Analysis

  • Hospital Pharmacies: Expected growth of 3.5%-7.5%, driven by acute CVD cases. Trends focus on specialized care delivery.
  • Retail Pharmacies: Projected growth of 3.2%-7.2%, linked to outpatient prescriptions. Advances emphasize accessibility.
  • Online Pharmacies: Anticipated growth of 3.8%-7.8%, driven by consumer convenience. Trends highlight digital platforms.

Type Analysis

  • Vascepa: Expected growth of 4.0%-8.0%, valued for high-purity EPA. Trends focus on expanded CVD indications.
  • Lovaza: Projected growth of 3.0%-7.0%, effective for triglyceride reduction. Developments prioritize generic competition.
  • Others: Anticipated growth of 3.5%-7.5%, covering plant-based formulations. Trends highlight sustainable omega-3 sources.

Key Market Players

  • Amarin Pharmaceuticals Ireland Limited: Pioneers Vascepa for CVD risk reduction.
  • GSK: Offers Lovaza for triglyceride management.
  • Dr. Reddy’s Laboratories: Supplies generic omega-3 formulations.
  • Hikma Pharmaceuticals: Provides affordable CVD treatments.
  • Abbott Laboratories: Develops omega-3-based therapies.

Porter’s Five Forces Analysis

  • Threat of New Entrants: Moderate, as high R&D costs and regulatory hurdles exist, but generics lower barriers.
  • Threat of Substitutes: Moderate, with OTC omega-3 supplements competing, but prescription drugs offer precise dosing.
  • Bargaining Power of Buyers: High, due to generic availability driving price competition.
  • Bargaining Power of Suppliers: Low, with multiple suppliers of active ingredients.
  • Competitive Rivalry: High, with companies competing on efficacy, cost, and novel formulations.

Market Opportunities and Challenges

Opportunities:

  • Addressing CVD, causing 17.9 million deaths annually.
  • Targeting 25% of U.S. adults with high triglycerides.
  • Leveraging an aging population, projected at 2.1 billion by 2050.
  • Utilizing novel formulations, improving bioavailability by 10%.
  • Benefiting from AHA and WHO endorsements.
  • Expanding plant-based omega-3 options.

Challenges:

  • Price erosion due to generic competition.
  • Competition from OTC supplements.
  • Regulatory delays for new indications.
  • Limited awareness in developing regions.
  • Supply chain issues for sustainable sources.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Omega 3 Prescription Drug Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Omega 3 Prescription Drug Market in North America (2020-2030)
8.1 Omega 3 Prescription Drug Market Size
8.2 Omega 3 Prescription Drug Market by End Use
8.3 Competition by Players/Suppliers
8.4 Omega 3 Prescription Drug Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Omega 3 Prescription Drug Market in South America (2020-2030)
9.1 Omega 3 Prescription Drug Market Size
9.2 Omega 3 Prescription Drug Market by End Use
9.3 Competition by Players/Suppliers
9.4 Omega 3 Prescription Drug Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Omega 3 Prescription Drug Market in Asia & Pacific (2020-2030)
10.1 Omega 3 Prescription Drug Market Size
10.2 Omega 3 Prescription Drug Market by End Use
10.3 Competition by Players/Suppliers
10.4 Omega 3 Prescription Drug Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Omega 3 Prescription Drug Market in Europe (2020-2030)
11.1 Omega 3 Prescription Drug Market Size
11.2 Omega 3 Prescription Drug Market by End Use
11.3 Competition by Players/Suppliers
11.4 Omega 3 Prescription Drug Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Omega 3 Prescription Drug Market in MEA (2020-2030)
12.1 Omega 3 Prescription Drug Market Size
12.2 Omega 3 Prescription Drug Market by End Use
12.3 Competition by Players/Suppliers
12.4 Omega 3 Prescription Drug Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Omega 3 Prescription Drug Market (2020-2025)
13.1 Omega 3 Prescription Drug Market Size
13.2 Omega 3 Prescription Drug Market by End Use
13.3 Competition by Players/Suppliers
13.4 Omega 3 Prescription Drug Market Size by Type
Chapter 14 Global Omega 3 Prescription Drug Market Forecast (2025-2030)
14.1 Omega 3 Prescription Drug Market Size Forecast
14.2 Omega 3 Prescription Drug Application Forecast
14.3 Competition by Players/Suppliers
14.4 Omega 3 Prescription Drug Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Amarin Pharmaceuticals Ireland Limited
15.1.1 Company Profile
15.1.2 Main Business and Omega 3 Prescription Drug Information
15.1.3 SWOT Analysis of Amarin Pharmaceuticals Ireland Limited
15.1.4 Amarin Pharmaceuticals Ireland Limited Omega 3 Prescription Drug Revenue, Gross Margin and Market Share (2020-2025)
15.2 GSK
15.2.1 Company Profile
15.2.2 Main Business and Omega 3 Prescription Drug Information
15.2.3 SWOT Analysis of GSK
15.2.4 GSK Omega 3 Prescription Drug Revenue, Gross Margin and Market Share (2020-2025)
15.3 Woodward Pharma Services
15.3.1 Company Profile
15.3.2 Main Business and Omega 3 Prescription Drug Information
15.3.3 SWOT Analysis of Woodward Pharma Services
15.3.4 Woodward Pharma Services Omega 3 Prescription Drug Revenue, Gross Margin and Market Share (2020-2025)
15.4 Camber Pharmaceuticals
15.4.1 Company Profile
15.4.2 Main Business and Omega 3 Prescription Drug Information
15.4.3 SWOT Analysis of Camber Pharmaceuticals
15.4.4 Camber Pharmaceuticals Omega 3 Prescription Drug Revenue, Gross Margin and Market Share (2020-2025)
15.5 Dr. Reddy’s Laboratories
15.5.1 Company Profile
15.5.2 Main Business and Omega 3 Prescription Drug Information
15.5.3 SWOT Analysis of Dr. Reddy’s Laboratories
15.5.4 Dr. Reddy’s Laboratories Omega 3 Prescription Drug Revenue, Gross Margin and Market Share (2020-2025)
15.6 Grupo Ferrer Internacional
15.6.1 Company Profile
15.6.2 Main Business and Omega 3 Prescription Drug Information
15.6.3 SWOT Analysis of Grupo Ferrer Internacional
15.6.4 Grupo Ferrer Internacional Omega 3 Prescription Drug Revenue, Gross Margin and Market Share (2020-2025)
15.7 Hikma Pharmaceuticals
15.7.1 Company Profile
15.7.2 Main Business and Omega 3 Prescription Drug Information
15.7.3 SWOT Analysis of Hikma Pharmaceuticals
15.7.4 Hikma Pharmaceuticals Omega 3 Prescription Drug Revenue, Gross Margin and Market Share (2020-2025)
15.8 Zydus Group
15.8.1 Company Profile
15.8.2 Main Business and Omega 3 Prescription Drug Information
15.8.3 SWOT Analysis of Zydus Group
15.8.4 Zydus Group Omega 3 Prescription Drug Revenue, Gross Margin and Market Share (2020-2025)
15.9 Abbott Laboratories
15.9.1 Company Profile
15.9.2 Main Business and Omega 3 Prescription Drug Information
15.9.3 SWOT Analysis of Abbott Laboratories
15.9.4 Abbott Laboratories Omega 3 Prescription Drug Revenue, Gross Margin and Market Share (2020-2025)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Omega 3 Prescription Drug Report
Table Data Sources of Omega 3 Prescription Drug Report
Table Major Assumptions of Omega 3 Prescription Drug Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Omega 3 Prescription Drug Picture
Table Omega 3 Prescription Drug Classification
Table Omega 3 Prescription Drug Applications
Table Drivers of Omega 3 Prescription Drug Market
Table Restraints of Omega 3 Prescription Drug Market
Table Opportunities of Omega 3 Prescription Drug Market
Table Threats of Omega 3 Prescription Drug Market
Table COVID-19 Impact For Omega 3 Prescription Drug Market
Table Raw Materials Suppliers
Table Different Production Methods of Omega 3 Prescription Drug
Table Cost Structure Analysis of Omega 3 Prescription Drug
Table Key End Users
Table Latest News of Omega 3 Prescription Drug Market
Table Merger and Acquisition
Table Planned/Future Project of Omega 3 Prescription Drug Market
Table Policy of Omega 3 Prescription Drug Market
Table 2020-2030 North America Omega 3 Prescription Drug Market Size
Figure 2020-2030 North America Omega 3 Prescription Drug Market Size and CAGR
Table 2020-2030 North America Omega 3 Prescription Drug Market Size by Application
Table 2020-2025 North America Omega 3 Prescription Drug Key Players Revenue
Table 2020-2025 North America Omega 3 Prescription Drug Key Players Market Share
Table 2020-2030 North America Omega 3 Prescription Drug Market Size by Type
Table 2020-2030 United States Omega 3 Prescription Drug Market Size
Table 2020-2030 Canada Omega 3 Prescription Drug Market Size
Table 2020-2030 Mexico Omega 3 Prescription Drug Market Size
Table 2020-2030 South America Omega 3 Prescription Drug Market Size
Figure 2020-2030 South America Omega 3 Prescription Drug Market Size and CAGR
Table 2020-2030 South America Omega 3 Prescription Drug Market Size by Application
Table 2020-2025 South America Omega 3 Prescription Drug Key Players Revenue
Table 2020-2025 South America Omega 3 Prescription Drug Key Players Market Share
Table 2020-2030 South America Omega 3 Prescription Drug Market Size by Type
Table 2020-2030 Brazil Omega 3 Prescription Drug Market Size
Table 2020-2030 Argentina Omega 3 Prescription Drug Market Size
Table 2020-2030 Chile Omega 3 Prescription Drug Market Size
Table 2020-2030 Peru Omega 3 Prescription Drug Market Size
Table 2020-2030 Asia & Pacific Omega 3 Prescription Drug Market Size
Figure 2020-2030 Asia & Pacific Omega 3 Prescription Drug Market Size and CAGR
Table 2020-2030 Asia & Pacific Omega 3 Prescription Drug Market Size by Application
Table 2020-2025 Asia & Pacific Omega 3 Prescription Drug Key Players Revenue
Table 2020-2025 Asia & Pacific Omega 3 Prescription Drug Key Players Market Share
Table 2020-2030 Asia & Pacific Omega 3 Prescription Drug Market Size by Type
Table 2020-2030 China Omega 3 Prescription Drug Market Size
Table 2020-2030 India Omega 3 Prescription Drug Market Size
Table 2020-2030 Japan Omega 3 Prescription Drug Market Size
Table 2020-2030 South Korea Omega 3 Prescription Drug Market Size
Table 2020-2030 Southeast Asia Omega 3 Prescription Drug Market Size
Table 2020-2030 Australia Omega 3 Prescription Drug Market Size
Table 2020-2030 Europe Omega 3 Prescription Drug Market Size
Figure 2020-2030 Europe Omega 3 Prescription Drug Market Size and CAGR
Table 2020-2030 Europe Omega 3 Prescription Drug Market Size by Application
Table 2020-2025 Europe Omega 3 Prescription Drug Key Players Revenue
Table 2020-2025 Europe Omega 3 Prescription Drug Key Players Market Share
Table 2020-2030 Europe Omega 3 Prescription Drug Market Size by Type
Table 2020-2030 Germany Omega 3 Prescription Drug Market Size
Table 2020-2030 France Omega 3 Prescription Drug Market Size
Table 2020-2030 United Kingdom Omega 3 Prescription Drug Market Size
Table 2020-2030 Italy Omega 3 Prescription Drug Market Size
Table 2020-2030 Spain Omega 3 Prescription Drug Market Size
Table 2020-2030 Belgium Omega 3 Prescription Drug Market Size
Table 2020-2030 Netherlands Omega 3 Prescription Drug Market Size
Table 2020-2030 Austria Omega 3 Prescription Drug Market Size
Table 2020-2030 Poland Omega 3 Prescription Drug Market Size
Table 2020-2030 Russia Omega 3 Prescription Drug Market Size
Table 2020-2030 MEA Omega 3 Prescription Drug Market Size
Figure 2020-2030 MEA Omega 3 Prescription Drug Market Size and CAGR
Table 2020-2030 MEA Omega 3 Prescription Drug Market Size by Application
Table 2020-2025 MEA Omega 3 Prescription Drug Key Players Revenue
Table 2020-2025 MEA Omega 3 Prescription Drug Key Players Market Share
Table 2020-2030 MEA Omega 3 Prescription Drug Market Size by Type
Table 2020-2030 Egypt Omega 3 Prescription Drug Market Size
Table 2020-2030 Israel Omega 3 Prescription Drug Market Size
Table 2020-2030 South Africa Omega 3 Prescription Drug Market Size
Table 2020-2030 Gulf Cooperation Council Countries Omega 3 Prescription Drug Market Size
Table 2020-2030 Turkey Omega 3 Prescription Drug Market Size
Table 2020-2025 Global Omega 3 Prescription Drug Market Size by Region
Table 2020-2025 Global Omega 3 Prescription Drug Market Size Share by Region
Table 2020-2025 Global Omega 3 Prescription Drug Market Size by Application
Table 2020-2025 Global Omega 3 Prescription Drug Market Share by Application
Table 2020-2025 Global Omega 3 Prescription Drug Key Vendors Revenue
Figure 2020-2025 Global Omega 3 Prescription Drug Market Size and Growth Rate
Table 2020-2025 Global Omega 3 Prescription Drug Key Vendors Market Share
Table 2020-2025 Global Omega 3 Prescription Drug Market Size by Type
Table 2020-2025 Global Omega 3 Prescription Drug Market Share by Type
Table 2025-2030 Global Omega 3 Prescription Drug Market Size by Region
Table 2025-2030 Global Omega 3 Prescription Drug Market Size Share by Region
Table 2025-2030 Global Omega 3 Prescription Drug Market Size by Application
Table 2025-2030 Global Omega 3 Prescription Drug Market Share by Application
Table 2025-2030 Global Omega 3 Prescription Drug Key Vendors Revenue
Figure 2025-2030 Global Omega 3 Prescription Drug Market Size and Growth Rate
Table 2025-2030 Global Omega 3 Prescription Drug Key Vendors Market Share
Table 2025-2030 Global Omega 3 Prescription Drug Market Size by Type
Table 2025-2030 Omega 3 Prescription Drug Global Market Share by Type

Companies Mentioned

  • Amarin Pharmaceuticals Ireland Limited
  • GSK
  • Woodward Pharma Services
  • Camber Pharmaceuticals
  • Dr. Reddy’s Laboratories
  • Grupo Ferrer Internacional
  • Hikma Pharmaceuticals
  • Zydus Group
  • Abbott Laboratories

Related Topics

Related Reports

Omega 3 Prescription Drugs - Global Strategic Business Report - Product Image

Omega 3 Prescription Drugs - Global Strategic Business Report

  • Report
  • 378 Pages
  • Global
From
Omega 3 Prescription Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Omega 3 Prescription Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 186 Pages
  • Global
From
Omega 3 Prescription Drugs Market Size, Share & Trends Analysis Report By Drug, By Application, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Omega 3 Prescription Drugs Market Size, Share & Trends Analysis Report By Drug, By Application, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 80 Pages
  • Global
From
Omega 3 Prescription Drugs Market Report 2025 - Product Image

Omega 3 Prescription Drugs Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Algae Omega-3 Ingredients Market by Application, Source, Form, Production Technology, Purity, Distribution Channel - Global Forecast to 2030 - Product Image

Algae Omega-3 Ingredients Market by Application, Source, Form, Production Technology, Purity, Distribution Channel - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.